Ziagen

DRUG2 trials

Sponsors

GlaxoSmithKline, Cellceutix Corporation

Conditions

HIV InfectionInfection, Human Immunodeficiency VirusPsoriasis

Phase 1

Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers

CompletedNCT02101216

Cellceutix CorporationPsoriasis

Start: 2014-03-31End: 2014-10-31Updated: 2018-10-26

Phase 3

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

CompletedNCT00085943

GlaxoSmithKlineHIV Infection, Infection, Human Immunodeficiency Virus

Start: 2004-05-31Target: 866Updated: 2011-05-16

Related Papers

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial.

2006-08-01223 citations